Un aperçu des interventions de prévention du VIH pour les usagers de drogues injectables en Tanzanie

Cet article décrit la mise en œuvre d'un large éventail d'interventions de réduction des risques, y compris le traitement de substitution, les programmes d’échange de seringues et d’aiguilles, et les «maisons de sobriété» pour le traitement résidentiel en Tanzanie. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

In the past decade, Tanzania has seen a rapid rise in the number of people who inject drugs (PWID), specifically heroin. While the overall HIV prevalence in Tanzania has declined recently to 5.6%, in 2009, the HIV prevalence among PWID remains alarmingly high at 35%.

This paper describes how the Tanzania AIDS Prevention Program (TAPP), Médecins du Monde France (MdM-F), and other organisations have been at the forefront of addressing this public health issue in Africa, implementing a wide array of harm reduction interventions including medication-assisted treatment (MAT), needle and syringe programs (NSP), and “sober houses” for residential treatment in the capital, Dar es Salaam, and in Zanzibar.

Looking toward the future, the authors discuss the need to extend existing services and programs to reach more PWID and others at risk for HIV, develop additional programs to strengthen existing programs, and expand activities to include structural interventions to address vulnerabilities that increase HIV risk for all Tanzanians.

Read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.